EUVIMEDEUVIMED entdecken
Open Access

Methylation of ESRα Promoters in Benign Breast Tumors Could Be a Signature for Progression to Breast Cancer in African American Women

Sylvia Dasi, Tammey J Naab, Bernard Kwabi-Addo, Victor Apprey, Desta Beyene, Robert L Dewitty, Steven Nagel, Robin Williams, Kelly Bolden, Andrea Hayes-Dixon, Babak Shokrani, Delisha A Stewart und 3 weitere

Cancer Genomics - Proteomics · 2025

DOI: 10.21873/cgp.20497 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Genomics - Proteomics, 2025. Verfasst von Sylvia Dasi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Howard University Cancer Center, Howard University, Washington, DC, U.S.A. Hauptthemen laut MEDLINE: Estrogen Receptor alpha, DNA Methylation, Promoter Regions, Genetic, Breast Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Estrogen Receptor alphaDNA MethylationPromoter Regions, GeneticBreast NeoplasmsBlack or African AmericanFibroadenomaHumansFemaleDisease ProgressionMiddle AgedAdultBiomarkers, TumorTumor Suppressor Proteins

Stichwörter der Autor:innen

DNA methylationbreast cancerestrogen receptor alphafibroadenoma

Substanzen

Estrogen Receptor alphaESR1 protein, humanBiomarkers, TumorTumor Suppressor Proteins

Autor:innen und Institutionen

  • Howard University Cancer Center, Howard University, Washington, DC, U.S.A.
  • Athari Biosciences, Sterling, VA, U.S.A.
  • Department of Biochemistry and Molecular Biology, Howard University College of Medicine, Howard University, Washington, DC, U.S.A.
  • Department of Surgery, Howard University Hospital, Washington, DC, U.S.A.
  • Department of Pathology, Howard University Hospital, Washington, DC, U.S.A.
  • Department of Microbiology, Howard University College of Medicine, Howard University, Washington, DC, U.S.A.

Zitieren

APA

Dasi, S., Naab, T. J., Kwabi-Addo, B., Apprey, V., Beyene, D., Dewitty, R. L., Nagel, S., Williams, R., Bolden, K., Hayes-Dixon, A., Shokrani, B., Stewart, D. A., Kassim, O. O., Copeland, R. L., & Kanaan, Y. M. (2025). Methylation of ESRα Promoters in Benign Breast Tumors Could Be a Signature for Progression to Breast Cancer in African American Women. Cancer Genomics - Proteomics. https://doi.org/10.21873/cgp.20497

Vancouver

Dasi S, Naab TJ, Kwabi-Addo B, Apprey V, Beyene D, Dewitty RL, et al. Methylation of ESRα Promoters in Benign Breast Tumors Could Be a Signature for Progression to Breast Cancer in African American Women. Cancer Genomics - Proteomics. 2025. doi:10.21873/cgp.20497

BibTeX
@article{Dasi2025,
  author = {Dasi, Sylvia and Naab, Tammey J and Kwabi-Addo, Bernard and Apprey, Victor and Beyene, Desta and Dewitty, Robert L and Nagel, Steven and Williams, Robin and Bolden, Kelly and Hayes-Dixon, Andrea and Shokrani, Babak and Stewart, Delisha A and Kassim, Olakunle O and Copeland, Robert L and Kanaan, Yasmine M},
  title = {Methylation of ESRα Promoters in Benign Breast Tumors Could Be a Signature for Progression to Breast Cancer in African American Women},
  journal = {Cancer Genomics - Proteomics},
  year = {2025},
  doi = {10.21873/cgp.20497}
}
Kostenlos starten →